Geneoscopy announced that CMS has granted Medicare coverage for ColoSense®, the first FDA-approved stool RNA test for colorectal cancer screening,…
Browsing: Clinical Updates
Researchers at Wilmington, Del.-based ChristianaCare’s Helen F. Graham Cancer Center & Research Institute identified a developmental genetic pattern tied to…
Prior authorizations remain a major barrier to IBD care, with surveys showing that nearly all gastroenterologists view them as burdensome…
Personalized nutrition is emerging as a major trend in gastroenterology, using microbiome data, biomarkers, genetics, and AI to tailor dietary…
Mindray has expanded its Hepatus ultrasound platform, combining diagnostic ultrasound with elastography and AI-powered image acquisition to create a unified…
NYU Langone is among the first U.S. centers using magnetic compression anastomosis, a novel technology that replaces staples with self-forming…
A large study of more than 11,000 patients found that virtual multidisciplinary GI care—combining gastroenterology, nutrition, behavioral health, and care…
The American Cancer Society (ACS) has reaffirmed that average-risk adults should begin colorectal cancer screening at age 45 and continue…
Overlap of symptoms in eosinophilic esophagitis and other conditions such as gastroesophageal reflux disease can make careful and accurate diagnosis…
Edulis Therapeutics is developing a bioresorbable, endoscopically delivered drug depot designed to provide sustained, localized therapy for chronic GI conditions…